{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:31:45Z","timestamp":1790875905758,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200887"],"award-info":[{"award-number":["82200887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["BK20220716"],"award-info":[{"award-number":["BK20220716"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M7114034"],"award-info":[{"award-number":["2022M7114034"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02438-y","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:13:30Z","timestamp":1760523210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jin-Hua","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Heng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Xiang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"6","key":"2438_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11899-016-0353-y","volume":"11","author":"A Phan","year":"2016","unstructured":"Phan A, Veldman R, Lechowicz MJ. T-cell lymphoma epidemiology: the known and unknown [J]. Curr Hematol Malig Rep. 2016;11(6):492\u2013503.","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"2438_CR2","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/S2352-3026(20)30207-6","volume":"7","author":"H Ma","year":"2020","unstructured":"Ma H, Marchi E, O\u2019Connor OA. The peripheral T-cell lymphomas: an unusual path to cure [J]. Lancet Haematol. 2020;7(10):e765\u201371.","journal-title":"Lancet Haematol"},{"issue":"1","key":"2438_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","volume":"21","author":"W Li","year":"2022","unstructured":"Li W, Liu JB, Hou LK, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring [J]. Mol Cancer. 2022;21(1):25.","journal-title":"Mol Cancer"},{"key":"2438_CR4","doi-asserted-by":"crossref","unstructured":"Liang JH, Wu YF, Shen HR et al. Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma [J]. Leukemia. 2024;38(7):1541\u20131552.","DOI":"10.1038\/s41375-024-02279-7"},{"issue":"12","key":"2438_CR5","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood.2021012852","volume":"139","author":"L Meriranta","year":"2022","unstructured":"Meriranta L, Alkodsi A, Pasanen A, et al. Molecular features encoded in the ctdna reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma [J]. Blood. 2022;139(12):1863\u201377.","journal-title":"Blood"},{"issue":"9","key":"2438_CR6","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1200\/JCO.22.00826","volume":"41","author":"JA Mutter","year":"2023","unstructured":"Mutter JA, Alig SK, Esfahani MS, et al. Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas [J]. J Clin Oncol. 2023;41(9):1684\u201394.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2438_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1053\/j.seminhematol.2023.06.007","volume":"60","author":"AK Foerster","year":"2023","unstructured":"Foerster AK, Lauer EM, Scherer F. Clinical applications of Circulating tumor DNA in central nervous system lymphoma [J]. Semin Hematol. 2023;60(3):150\u20136.","journal-title":"Semin Hematol"},{"issue":"1","key":"2438_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/2643-3230.BCD-21-0029","volume":"3","author":"M Roschewski","year":"2022","unstructured":"Roschewski M, Rossi D, Kurtz DM, et al. Circulating tumor DNA in lymphoma: principles and future directions [J]. Blood Cancer Discov. 2022;3(1):5\u201315.","journal-title":"Blood Cancer Discov"},{"issue":"27","key":"2438_CR9","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification [J]. J Clin Oncol. 2014;32(27):3059\u201368.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2438_CR10","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41467-021-27022-z","volume":"12","author":"B Qiu","year":"2021","unstructured":"Qiu B, Guo W, Zhang F, et al. Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctdna in resected NSCLC [J]. Nat Commun. 2021;12(1):6770.","journal-title":"Nat Commun"},{"issue":"26","key":"2438_CR11","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood.2023022222","volume":"142","author":"LD Weeks","year":"2023","unstructured":"Weeks LD, Ebert BL. Causes and consequences of clonal hematopoiesis [J]. Blood. 2023;142(26):2235\u201346.","journal-title":"Blood"},{"issue":"3","key":"2438_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1158\/2643-3230.BCD-20-0094","volume":"2","author":"JE Feusier","year":"2021","unstructured":"Feusier JE, Arunachalam S, Tashi T, et al. Large-Scale identification of clonal hematopoiesis and mutations recurrent in blood cancers [J]. Blood Cancer Discov. 2021;2(3):226\u201337.","journal-title":"Blood Cancer Discov"},{"issue":"4","key":"2438_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11912-017-0582-9","volume":"19","author":"RF Sandell","year":"2017","unstructured":"Sandell RF, Boddicker RL, Feldman AL. Genetic landscape and classification of peripheral T cell lymphomas [J]. Curr Oncol Rep. 2017;19(4):28.","journal-title":"Curr Oncol Rep"},{"issue":"D1","key":"2438_CR14","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, et al. KEGG for taxonomy-based analysis of pathways and genomes [J]. Nucleic Acids Res. 2023;51(D1):D587\u201392.","journal-title":"Nucleic Acids Res"},{"key":"2438_CR15","unstructured":"Aleksander SA, Balhoff J, Carbon S et al. The gene ontology knowledgebase in 2023 [J]. Genetics. 2023;224(1):iyad031."},{"issue":"21","key":"2438_CR16","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: A web server for comprehensive analysis of Tumor-Infiltrating immune cells [J]. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"key":"2438_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, et al. Profiling tumor infiltrating immune cells with CIBERSORT [J]. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2438_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, et al. Molecular and Pharmacological modulators of the tumor immune contexture revealed by Deconvolution of RNA-seq data [J]. Genome Med. 2019;11(1):34.","journal-title":"Genome Med"},{"key":"2438_CR19","doi-asserted-by":"crossref","unstructured":"Peng Q, Xie T, Wang Y et al. GLIS1, correlated with immune infiltrates, is a potential prognostic biomarker in prostate cancer [J]. Int J Mol Sci. 2023;25(1):489.","DOI":"10.3390\/ijms25010489"},{"key":"2438_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","volume":"2120","author":"D Aran","year":"2020","unstructured":"Aran D. Cell-Type enrichment analysis of bulk transcriptomes using xCell [J]. Methods Mol Biol. 2020;2120:263\u201376.","journal-title":"Methods Mol Biol"},{"key":"2438_CR21","doi-asserted-by":"crossref","unstructured":"Racle J, de Jonge K, Baumgaertner P et al. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data [J]. Elife. 2017;6:e26476.","DOI":"10.7554\/eLife.26476"},{"issue":"2","key":"2438_CR22","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.xcrm.2024.101416","volume":"5","author":"YH Huang","year":"2024","unstructured":"Huang YH, Qiu YR, Zhang QL, et al. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes [J]. Cell Rep Med. 2024;5(2):101416.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2438_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade [J]. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"21","key":"2438_CR24","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J]. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2438_CR25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s41590-024-01821-0","volume":"25","author":"SJ Sammut","year":"2024","unstructured":"Sammut SJ, Galson JD, Minter R, et al. Predictability of B cell clonal persistence and immunosurveillance in breast cancer [J]. Nat Immunol. 2024;25(5):916\u201324.","journal-title":"Nat Immunol"},{"issue":"8","key":"2438_CR26","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/leu.2014.13","volume":"28","author":"L Melchor","year":"2014","unstructured":"Melchor L, Brioli A, Wardell CP, et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma [J]. Leukemia. 2014;28(8):1705\u201315.","journal-title":"Leukemia"},{"issue":"1","key":"2438_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4143\/crt.2022.017","volume":"55","author":"SJ Kim","year":"2023","unstructured":"Kim SJ, Kim YJ, Yoon SE, et al. Circulating tumor DNA-Based genotyping and monitoring for predicting disease relapses of patients with peripheral T-Cell lymphomas [J]. Cancer Res Treat. 2023;55(1):291\u2013303.","journal-title":"Cancer Res Treat"},{"issue":"5","key":"2438_CR28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/bjh.19280","volume":"204","author":"E Fardella","year":"2024","unstructured":"Fardella E, Zanirato G, Magni M, et al. Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas [J]. Br J Haematol. 2024;204(5):1752\u20136.","journal-title":"Br J Haematol"},{"issue":"1","key":"2438_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/bjh.18824","volume":"202","author":"C Wei","year":"2023","unstructured":"Wei C, Wang W, Zhang Y, et al. Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by Circulating tumour DNA in peripheral T-cell lymphoma [J]. Br J Haematol. 2023;202(1):86\u201395.","journal-title":"Br J Haematol"},{"issue":"2","key":"2438_CR30","doi-asserted-by":"publisher","first-page":"100859","DOI":"10.1016\/j.xcrm.2022.100859","volume":"4","author":"XP Tian","year":"2023","unstructured":"Tian XP, Zhang YC, Lin NJ, et al. Diagnostic performance and prognostic value of Circulating tumor DNA methylation marker in extranodal natural killer\/t cell lymphoma [J]. Cell Rep Med. 2023;4(2):100859.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2438_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-024-01825-0","volume":"9","author":"Y Gao","year":"2024","unstructured":"Gao Y, He H, Li X, et al. Sintilimab (anti-PD-1 antibody) plus Chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase ib\/ii study [J]. Signal Transduct Target Ther. 2024;9(1):121.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2438_CR32","doi-asserted-by":"publisher","first-page":"e822","DOI":"10.1097\/HS9.0000000000000822","volume":"7","author":"D Huang","year":"2023","unstructured":"Huang D, Li Q, Li X, et al. The novel prognostic index model of combining Circulating tumor DNA and PINK-E predicts the clinical outcomes for newly diagnosed extranodal NK\/T-cell lymphoma [J]. Hemasphere. 2023;7(1):e822.","journal-title":"Hemasphere"},{"issue":"15","key":"2438_CR33","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican TB, Bouska A, Yu J, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma [J]. Blood. 2019;133(15):1664\u201376.","journal-title":"Blood"},{"key":"2438_CR34","doi-asserted-by":"publisher","first-page":"1132834","DOI":"10.3389\/fimmu.2023.1132834","volume":"14","author":"C Xiang","year":"2023","unstructured":"Xiang C, Wu W, Fan M, et al. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK(-) ALCL vs. CD30(high) PTCL, NOS [J]. Front Immunol. 2023;14:1132834.","journal-title":"Front Immunol"},{"issue":"11","key":"2438_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41408-018-0138-8","volume":"8","author":"JJ Han","year":"2018","unstructured":"Han JJ, O\u2019Byrne M, Stenson MJ, et al. Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma [J]. Blood Cancer J. 2018;8(11):110.","journal-title":"Blood Cancer J"},{"key":"2438_CR36","doi-asserted-by":"crossref","unstructured":"Ong SY, Zain JM, Aggressive, T-cell lymphomas. 2024: Updates on diagnosis, risk stratification, and management [J]. Am J Hematol. 2024;99(3):439\u2013456.","DOI":"10.1002\/ajh.27165"},{"issue":"14","key":"2438_CR37","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1182\/blood-2016-05-719641","volume":"129","author":"D Rossi","year":"2017","unstructured":"Rossi D, Diop F, Spaccarotella E, et al. Diffuse large B-cell lymphoma genotyping on the liquid biopsy [J]. Blood. 2017;129(14):1947\u201357.","journal-title":"Blood"},{"issue":"12","key":"2438_CR38","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/leu.2016.135","volume":"30","author":"D Juskevicius","year":"2016","unstructured":"Juskevicius D, Lorber T, Gsponer J, et al. Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis [J]. Leukemia. 2016;30(12):2385\u201395.","journal-title":"Leukemia"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02438-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02438-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02438-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:13:33Z","timestamp":1760523213000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02438-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2438"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02438-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures fallowed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript and agree with submission to Cell Communication and Signaling.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"441"}}